BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//LifeSci Events - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LifeSci Events
X-ORIGINAL-URL:https://lifescievents.com
X-WR-CALDESC:Events for LifeSci Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261015T100000
DTEND;TZID=America/New_York:20261015T113000
DTSTAMP:20260923T191620
CREATED:20260831T183130Z
LAST-MODIFIED:20260923T160607Z
UID:3372-1792058400-1792063800@lifescievents.com
SUMMARY:enGene Therapeutics Inc. Detalimogene plus Surfactant KOL Webinar
DESCRIPTION:Join enGene for a webinar that will provide greater detail on the preclinical data supporting the incorporation of its surfactant bladder rinse plus detalimogene voraplasmid (detalimogene) into clinical development. Two community key opinion leaders (KOLs) from Colorado Urology\, David J. Cahn\, MD and Suzanne B. Merrill\, MD\, FACS\, will review clinical case studies and discuss various real-world treatment considerations. \nSurfactants have been shown to boost efficacy with other NMIBC gene therapies in preclinical models and were subsequently incorporated into clinical development of those gene therapies. enGene is currently enrolling high-risk\, BCG-unresponsive NMIBC patients with CIS in an additional cohort in its ongoing LEGEND trial\, which incorporates a short surfactant bladder rinse (generic name: polidocanol) prior to intravesical administration of detalimogene. Detalimogene is an investigational\, non-viral gene therapy designed for direct bladder instillation to treat high-risk\, Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC). \nA live question and answer session will follow the formal presentations. Watch the webcast by clicking this link and logging in with the email address you used to register: https://lifescievents.com/event/egjs02p/.
URL:https://lifescievents.com/event/egjs02p/
LOCATION:Virtual\, Virtual
ATTACH;FMTTYPE=image/png:https://lifescievents.com/wp-content/uploads/2026/08/enGene-Banner.png
END:VEVENT
END:VCALENDAR